AI Engines For more Details: Perplexity Kagi Labs You
Antihistamine Effects: Pyrilamine maleate works by blocking the action of histamine, a substance in the body that is involved in allergic reactions. By inhibiting histamine receptors, pyrilamine maleate helps alleviate symptoms such as itching, sneezing, runny nose, watery eyes, and hives.
Allergic Rhinitis: Pyrilamine maleate is commonly used to relieve symptoms of allergic rhinitis, also known as hay fever. It helps reduce nasal congestion, sneezing, itching, and runny nose caused by allergens such as pollen, dust mites, pet dander, and mold.
Allergic Conjunctivitis: Pyrilamine maleate may also be used to alleviate symptoms of allergic conjunctivitis, including redness, itching, and watering of the eyes due to exposure to allergens.
Urticaria (Hives): Pyrilamine maleate can help relieve the itching and swelling associated with acute and chronic urticaria, commonly known as hives. It blocks histamine receptors in the skin, reducing the allergic response and alleviating symptoms.
Pruritus (Itching): Pyrilamine maleate is sometimes used to relieve generalized itching associated with various skin conditions, including eczema, dermatitis, and insect bites.
Motion Sickness: Pyrilamine maleate has mild sedative properties and may be used to prevent motion sickness and alleviate symptoms such as nausea and vomiting during travel.
Side Effects: Common side effects of pyrilamine maleate may include drowsiness, dizziness, dry mouth, blurred vision, constipation, and urinary retention. These side effects are typically mild and transient, but individuals should exercise caution when operating machinery or driving until they know how the medication affects them.
Central Nervous System Effects: Pyrilamine maleate can penetrate the blood-brain barrier, leading to central nervous system (CNS) effects such as sedation and drowsiness. This sedative effect may be enhanced when pyrilamine maleate is used concomitantly with other CNS depressants, such as alcohol or certain medications.
Drug Interactions: Pyrilamine maleate may interact with other medications, including central nervous system depressants, anticholinergic drugs, and certain antidepressants. These interactions can potentiate the sedative effects of pyrilamine maleate and increase the risk of adverse effects.
Special Populations: Pyrilamine maleate should be used with caution in elderly individuals, as they may be more susceptible to its sedative effects. It should also be used cautiously in children, as sedation and CNS effects may be more pronounced in this population.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Streptococcus thermophilus | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Streptococcus thermophilus | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.2 | 0.2 | |
Acne | 0.2 | -0.2 | |
ADHD | 2 | 0.3 | 5.67 |
Age-Related Macular Degeneration and Glaucoma | 0.6 | 0.6 | |
Allergic Rhinitis (Hay Fever) | 1.4 | 2 | -0.43 |
Allergies | 2.8 | 2.3 | 0.22 |
Allergy to milk products | 1.4 | 0.8 | 0.75 |
Alopecia (Hair Loss) | 0.3 | 0.3 | |
Alzheimer's disease | 3.7 | 3.7 | 0 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2 | 1 | 1 |
Ankylosing spondylitis | 2.5 | 0.5 | 4 |
Anorexia Nervosa | 0.6 | 1.1 | -0.83 |
Antiphospholipid syndrome (APS) | 0.8 | 0 | 0 |
Asthma | 2.8 | 2.4 | 0.17 |
Atherosclerosis | 1.2 | 0.7 | 0.71 |
Atrial fibrillation | 1.3 | 1.2 | 0.08 |
Autism | 4.5 | 4.9 | -0.09 |
Autoimmune Disease | 0.8 | 0.5 | 0.6 |
Barrett esophagus cancer | 0.2 | 0.3 | -0.5 |
benign prostatic hyperplasia | 0.3 | 0.2 | 0.5 |
Biofilm | 1.3 | 1.3 | |
Bipolar Disorder | 0.7 | 0.3 | 1.33 |
Brain Trauma | 0.5 | 0.7 | -0.4 |
Breast Cancer | 0.7 | 0.7 | |
Cancer (General) | 0.3 | 1.3 | -3.33 |
Carcinoma | 1.8 | 0.8 | 1.25 |
Celiac Disease | 1.7 | 1.2 | 0.42 |
Cerebral Palsy | 1.1 | 0.5 | 1.2 |
Chronic Fatigue Syndrome | 2.2 | 2.8 | -0.27 |
Chronic Kidney Disease | 2.4 | 1.7 | 0.41 |
Chronic Lyme | 0.4 | -0.4 | |
Chronic Obstructive Pulmonary Disease (COPD) | 1.8 | 0.8 | 1.25 |
Chronic Urticaria (Hives) | 1 | 1.1 | -0.1 |
Coagulation / Micro clot triggering bacteria | 1 | 0.5 | 1 |
Cognitive Function | 1 | 0.9 | 0.11 |
Colorectal Cancer | 4.5 | 1.6 | 1.81 |
Constipation | 0.9 | 0.3 | 2 |
Coronary artery disease | 1.4 | 1.1 | 0.27 |
COVID-19 | 5 | 7 | -0.4 |
Crohn's Disease | 4 | 2.7 | 0.48 |
Cushing's Syndrome (hypercortisolism) | 0.5 | -0.5 | |
cystic fibrosis | 0.6 | 1.2 | -1 |
d-lactic acidosis (one form of brain fog) | 0.4 | 0.4 | |
deep vein thrombosis | 1.5 | 0.7 | 1.14 |
Denture Wearers Oral Shifts | 1.3 | 1.3 | |
Depression | 5 | 4 | 0.25 |
Dermatomyositis | 0.3 | 0.2 | 0.5 |
Eczema | 1 | 1.8 | -0.8 |
Endometriosis | 1.7 | 0.9 | 0.89 |
Eosinophilic Esophagitis | 0.1 | 0.3 | -2 |
Epilepsy | 2.4 | 1.4 | 0.71 |
erectile dysfunction | 0.8 | 0.2 | 3 |
Fibromyalgia | 1 | 1.1 | -0.1 |
Functional constipation / chronic idiopathic constipation | 2.4 | 2.4 | 0 |
gallstone disease (gsd) | 1.4 | 0.9 | 0.56 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1 | 0.7 | 0.43 |
Generalized anxiety disorder | 1.8 | 1 | 0.8 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0.3 | -0.3 | |
Gout | 1.9 | 0.5 | 2.8 |
Graves' disease | 0.6 | 1.3 | -1.17 |
Gulf War Syndrome | 0.4 | 1.4 | -2.5 |
Halitosis | 1 | 0.3 | 2.33 |
Hashimoto's thyroiditis | 2.4 | 1.4 | 0.71 |
Heart Failure | 1.8 | 1.1 | 0.64 |
hemorrhagic stroke | 0.4 | 0.4 | |
Hidradenitis Suppurativa | 0.7 | 0.1 | 6 |
High Histamine/low DAO | 0.9 | 0.2 | 3.5 |
hypercholesterolemia (High Cholesterol) | 0.6 | 0.6 | 0 |
hyperglycemia | 1.8 | 1.4 | 0.29 |
Hyperlipidemia (High Blood Fats) | 0.6 | 0.1 | 5 |
hypersomnia | 0.2 | -0.2 | |
hypertension (High Blood Pressure | 2.9 | 2.7 | 0.07 |
Hypothyroidism | 0.3 | 0.3 | 0 |
Hypoxia | 1.2 | 1.2 | |
IgA nephropathy (IgAN) | 0.6 | 2.1 | -2.5 |
Inflammatory Bowel Disease | 5.1 | 4.6 | 0.11 |
Insomnia | 1.6 | 1.8 | -0.13 |
Intelligence | 1 | 0.3 | 2.33 |
Intracranial aneurysms | 0.4 | 0.1 | 3 |
Irritable Bowel Syndrome | 5.1 | 3 | 0.7 |
ischemic stroke | 1.2 | 0.8 | 0.5 |
Liver Cirrhosis | 4 | 3 | 0.33 |
Long COVID | 3.5 | 2.9 | 0.21 |
Low bone mineral density | 0.4 | -0.4 | |
Lung Cancer | 1 | 1.1 | -0.1 |
Lymphoma | 0.3 | 0.3 | |
Mast Cell Issues / mastitis | 0.9 | 0.2 | 3.5 |
ME/CFS with IBS | 0.3 | 1.6 | -4.33 |
ME/CFS without IBS | 0.6 | 1.3 | -1.17 |
membranous nephropathy | 0.3 | 0.3 | |
Menopause | 1.2 | 0.5 | 1.4 |
Metabolic Syndrome | 3.9 | 4.3 | -0.1 |
Mood Disorders | 5.2 | 3 | 0.73 |
multiple chemical sensitivity [MCS] | 1.3 | 0 | 0 |
Multiple Sclerosis | 3.7 | 2.4 | 0.54 |
Multiple system atrophy (MSA) | 1.6 | 0.3 | 4.33 |
myasthenia gravis | 0.6 | 0.3 | 1 |
neuropathic pain | 1.4 | -1.4 | |
Neuropathy (all types) | 0.6 | 0.6 | 0 |
neuropsychiatric disorders (PANDAS, PANS) | 0.7 | 0.7 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.1 | 2.5 | 0.24 |
NonCeliac Gluten Sensitivity | 1.1 | 0.4 | 1.75 |
Obesity | 6.4 | 4.6 | 0.39 |
obsessive-compulsive disorder | 2.6 | 2.7 | -0.04 |
Osteoarthritis | 1.6 | 1.1 | 0.45 |
Osteoporosis | 0.9 | 1.3 | -0.44 |
pancreatic cancer | 0.6 | 0.3 | 1 |
Parkinson's Disease | 4.9 | 3 | 0.63 |
Polycystic ovary syndrome | 2.2 | 1.4 | 0.57 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.2 | -1 |
Premenstrual dysphoric disorder | 0.3 | 0.3 | |
primary biliary cholangitis | 0.6 | 0.8 | -0.33 |
Primary sclerosing cholangitis | 1.1 | 0.6 | 0.83 |
Psoriasis | 2.2 | 1.5 | 0.47 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3.3 | 1.7 | 0.94 |
Rosacea | 0.8 | 0.3 | 1.67 |
Schizophrenia | 3.2 | 1.2 | 1.67 |
scoliosis | 0.5 | 0.1 | 4 |
sensorineural hearing loss | 0.2 | 0.2 | |
Sjögren syndrome | 1.3 | 1.5 | -0.15 |
Sleep Apnea | 0.8 | 0.5 | 0.6 |
Slow gastric motility / Gastroparesis | 0.7 | 0.2 | 2.5 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.2 | 1.2 | |
Stress / posttraumatic stress disorder | 2 | 1.3 | 0.54 |
Systemic Lupus Erythematosus | 1.5 | 0.7 | 1.14 |
Tic Disorder | 0.6 | 1 | -0.67 |
Tourette syndrome | 0.8 | 0.2 | 3 |
Type 1 Diabetes | 2.5 | 1.9 | 0.32 |
Type 2 Diabetes | 4.3 | 4.1 | 0.05 |
Ulcerative colitis | 3 | 3.8 | -0.27 |
Unhealthy Ageing | 2.4 | 1 | 1.4 |
Vitiligo | 0.9 | 0.7 | 0.29 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]